SH Ip

661 total citations
15 papers, 581 citations indexed

About

SH Ip is a scholar working on Immunology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, SH Ip has authored 15 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Pathology and Forensic Medicine and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in SH Ip's work include Lymphoma Diagnosis and Treatment (7 papers), Immune Cell Function and Interaction (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). SH Ip is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Immune Cell Function and Interaction (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). SH Ip collaborates with scholars based in United States. SH Ip's co-authors include RK Dodge, WM Crist, RA Cooper, CH Pui, CW Berard, Patrick Kung, Masao Matsuoka, Toshio Hattori, Purtilo Dt and Norimasa Yasuda and has published in prestigious journals such as Blood.

In The Last Decade

SH Ip

15 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SH Ip United States 10 353 141 114 106 88 15 581
Marilyne Sasportes France 14 551 1.6× 189 1.3× 137 1.2× 133 1.3× 104 1.2× 25 840
Edelson Rl United States 14 501 1.4× 335 2.4× 64 0.6× 183 1.7× 48 0.5× 28 827
Hirofumi Koshiba Japan 13 276 0.8× 81 0.6× 147 1.3× 155 1.5× 59 0.7× 33 545
G Sébahoun France 14 240 0.7× 133 0.9× 73 0.6× 151 1.4× 183 2.1× 61 585
Y Takihara Japan 17 635 1.8× 138 1.0× 298 2.6× 219 2.1× 169 1.9× 35 1.1k
S Ohzeki Japan 9 396 1.1× 77 0.5× 169 1.5× 167 1.6× 31 0.4× 9 633
Jane L. Rosbotham United Kingdom 8 416 1.2× 56 0.4× 124 1.1× 223 2.1× 36 0.4× 12 734
Sally M. Pittman Australia 15 206 0.6× 212 1.5× 232 2.0× 149 1.4× 100 1.1× 25 734
J H Phillips United States 9 828 2.3× 93 0.7× 79 0.7× 199 1.9× 186 2.1× 11 959
MF Gourdin France 13 324 0.9× 274 1.9× 99 0.9× 136 1.3× 107 1.2× 28 615

Countries citing papers authored by SH Ip

Since Specialization
Citations

This map shows the geographic impact of SH Ip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SH Ip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SH Ip more than expected).

Fields of papers citing papers by SH Ip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SH Ip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SH Ip. The network helps show where SH Ip may publish in the future.

Co-authorship network of co-authors of SH Ip

This figure shows the co-authorship network connecting the top 25 collaborators of SH Ip. A scholar is included among the top collaborators of SH Ip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SH Ip. SH Ip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Pui, CH, SH Ip, Elizabeth Thompson, et al.. (1989). Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome. Blood. 73(1). 209–213. 4 indexed citations
2.
Pui, C-H, SH Ip, Elizabeth Thompson, et al.. (1989). Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome. Blood. 73(1). 209–213. 40 indexed citations
3.
Pui, CH, SH Ip, FG Behm, et al.. (1988). Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemia. Blood. 71(4). 1135–1137. 5 indexed citations
4.
Pui, CH, SH Ip, FG Behm, et al.. (1988). Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemia. Blood. 71(4). 1135–1137. 66 indexed citations
5.
6.
7.
Yasuda, Norimasa, SH Ip, Masao Matsuoka, et al.. (1988). Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood. 71(4). 1021–1026. 84 indexed citations
8.
Yasuda, Norimasa, SH Ip, Masao Matsuoka, et al.. (1988). Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood. 71(4). 1021–1026. 72 indexed citations
9.
Pui, C-H, SH Ip, RK Dodge, et al.. (1987). High serum interleukin-2 receptor levels are related to advanced disease and a poor outcome in childhood non-Hodgkin's lymphoma. Blood. 70(3). 624–628. 1 indexed citations
10.
Pui, CH, SH Ip, Patrick Kung, et al.. (1987). High serum interleukin-2 receptor levels are related to advanced disease and a poor outcome in childhood non-Hodgkin's lymphoma. Blood. 70(3). 624–628. 85 indexed citations
11.
Ip, SH, et al.. (1982). Evaluation of E-rosetting human lymphocytes with OKT11 and other monoclonal antibodies. Blood. 60(3). 795–799. 19 indexed citations
12.
13.
14.
Ip, SH & RA Cooper. (1980). Decreased membrane fluidity during differentiation of human promyelocytic leukemia cells in culture. Blood. 56(2). 227–232. 56 indexed citations
15.
Ip, SH & RA Cooper. (1980). Decreased membrane fluidity during differentiation of human promyelocytic leukemia cells in culture. Blood. 56(2). 227–232. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marilyne Sasportes Breakdown of academic impact, for papers by Edelson Rl Breakdown of academic impact, for papers by Hirofumi Koshiba Breakdown of academic impact, for papers by G Sébahoun Breakdown of academic impact, for papers by Y Takihara Breakdown of academic impact, for papers by S Ohzeki Breakdown of academic impact, for papers by Jane L. Rosbotham Breakdown of academic impact, for papers by Sally M. Pittman Breakdown of academic impact, for papers by J H Phillips Breakdown of academic impact, for papers by MF Gourdin
Rankless by CCL
2026